Phio Pharmaceuticals (NASDAQ:PHIO) reported quarterly losses of $(0.19) per share. This is a 40.63 percent increase over losses of $(0.32) per share from the same period last year.
Raymond James Maintains Strong Buy on Banner, Raises Price Target to $68
Raymond James analyst David Feaster maintains Banner (NASDAQ:BANR) with a Strong Buy and raises the price target from $65 to $68.